The Chinese government has previously admitted "shortcomings and deficiencies" in its response to the virus, which has now killed 636 people and infected 31,161 in mainland China.
MARKET REPORT: Stocks around world soar as latest breakthrough in US-China trade war and hopes a vaccine could be around corner for coronavirus boost optimism
I have looked at HUR but never traded it but now looks like you can gain few pennies there, but then i do like to buy in to LLOY around 55 - 56p for long term . I reckoned banks will do well this year.
Hi Gerry , that is part of the game mate, we cannot get them right all of the time but when we do feels nice to beat the market. I have got small trade in SPT on Monday at 216p . I don't know how long i will be there but i like to stay in till the results . SAGA looks good at 40p again but then the virus is still around.I rarely buy AIM shares but i had few which i was very happy with HGM, AAZ and PLUS now FTSE 250 (now i wish i still got them) and now i have been in IXI for a while and i will keep it for bit longer you never know.
ASHM would help here today good results, i have been following NANO for a long time but collapse of share price put me off and they are up for sale but you have done well.
no problem at all, pull the other one Price£1.193735 Order DetailsSettlement DateT+2 - 07/02/20Cost of Shares£11,937.35Commission£7.99Stamp Duty£59.69PTM Levy£1.00Total To Pay£12,006.03
EVRAZ (LON:EVR) had its price target increased by JPMorgan Chase & Co. from GBX 400 ($5.26) to GBX 405 ($5.33) in a research report report published on Friday, Digital Look reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.